S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
S&P 500   3,335.47 (-0.48%)
DOW   27,452.66 (-0.48%)
QQQ   275.95 (-0.45%)
AAPL   114.09 (-0.76%)
MSFT   207.26 (-1.04%)
FB   261.79 (+1.94%)
GOOGL   1,466.02 (+0.50%)
AMZN   3,144.88 (-0.92%)
TSLA   419.07 (-0.51%)
NVDA   529.03 (+1.46%)
BABA   276.93 (+0.33%)
CGC   14.50 (+2.04%)
GE   6.12 (-1.29%)
MU   50.71 (+1.99%)
AMD   81.77 (+2.88%)
T   28.30 (-0.28%)
F   6.60 (-1.35%)
ACB   4.68 (-2.09%)
GILD   62.10 (-1.19%)
NFLX   493.48 (+0.58%)
DIS   125.40 (-0.47%)
BA   163.60 (-1.49%)
BAC   23.77 (-1.33%)
Log in
NASDAQ:ICUI

ICU Medical Stock Forecast, Price & News

$183.19
-2.29 (-1.23 %)
(As of 09/29/2020 12:00 AM ET)
Add
Compare
Today's Range
$183.01
Now: $183.19
$188.09
50-Day Range
$177.70
MA: $189.80
$200.24
52-Week Range
$148.89
Now: $183.19
$236.51
Volume72,583 shs
Average Volume159,282 shs
Market Capitalization$3.84 billion
P/E Ratio47.46
Dividend YieldN/A
Beta0.65
ICU Medical, Inc. develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein. The company's infusion therapy products include needlefree connector products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency connectors; SwabCap disinfecting caps; Tego hemodialysis connectors; NovaCath and SuperCath peripheral intravenous (IV) catheters; and ChemoLock and ChemoClave closed system transfer devices, as well as Diana hazardous drug compounding system for the preparation of hazardous drugs. It also provides IV therapy and diluents, including sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation/urologics, such as sodium chloride irrigation, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. In addition, the company offers infusion pumps under the Plum 360 and LifeCare PCA brands; Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. Further, it provides ICU Medical Mednet, an enterprise medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms. The company sells its products to acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California.
Read More
ICU Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.33 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:ICUI
CUSIP44930G10
Phone949-366-2183

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.27 billion
Cash Flow$11.26 per share
Book Value$66.62 per share

Profitability

Net Income$101.04 million

Miscellaneous

Employees8,000
Market Cap$3.84 billion
Next Earnings Date11/9/2020 (Estimated)
OptionableOptionable
$183.19
-2.29 (-1.23 %)
(As of 09/29/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ICUI News and Ratings via Email

Sign-up to receive the latest news and ratings for ICUI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











ICU Medical (NASDAQ:ICUI) Frequently Asked Questions

How has ICU Medical's stock been impacted by COVID-19?

ICU Medical's stock was trading at $180.56 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ICUI shares have increased by 1.5% and is now trading at $183.19.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of ICU Medical?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for ICU Medical
.

When is ICU Medical's next earnings date?

ICU Medical is scheduled to release its next quarterly earnings announcement on Monday, November 9th 2020.
View our earnings forecast for ICU Medical
.

How were ICU Medical's earnings last quarter?

ICU Medical, Incorporated (NASDAQ:ICUI) announced its quarterly earnings data on Monday, August, 10th. The medical instruments supplier reported $1.65 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.41. The medical instruments supplier had revenue of $303.40 million for the quarter, compared to the consensus estimate of $283.37 million. ICU Medical had a net margin of 6.61% and a return on equity of 9.77%. ICU Medical's revenue was down 2.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.99 earnings per share.
View ICU Medical's earnings history
.

What price target have analysts set for ICUI?

3 analysts have issued twelve-month price objectives for ICU Medical's stock. Their forecasts range from $210.00 to $218.00. On average, they anticipate ICU Medical's share price to reach $214.00 in the next year. This suggests a possible upside of 16.8% from the stock's current price.
View analysts' price targets for ICU Medical
.

Are investors shorting ICU Medical?

ICU Medical saw a increase in short interest in August. As of August 14th, there was short interest totaling 276,300 shares, an increase of 13.7% from the July 30th total of 243,100 shares. Based on an average daily volume of 146,100 shares, the days-to-cover ratio is currently 1.9 days. Approximately 1.4% of the shares of the company are sold short.
View ICU Medical's Short Interest
.

Who are some of ICU Medical's key competitors?

What other stocks do shareholders of ICU Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICU Medical investors own include Becton Dickinson and (BDX), BlackRock (BLK), NVIDIA (NVDA), Alibaba Group (BABA), CA (CA), UnitedHealth Group (UNH), Boeing (BA), Micron Technology (MU), Lockheed Martin (LMT) and ServiceNow (NOW).

Who are ICU Medical's key executives?

ICU Medical's management team includes the following people:
  • Mr. Vivek Jain, Chairman & CEO (Age 47)
  • Mr. Scott E. Lamb, CFO & Treasurer (Age 56)
  • Mr. Christian B. Voigtlander, Chief Operating Officer (Age 51)
  • Ms. Virginia Ruth Sanzone, Corp. VP, Gen. Counsel & Sec. (Age 44)
  • Mr. Thomas D. McCall, Corp. VP of Marketing & Communications and GM of Critical Care (Age 61)

What is ICU Medical's stock symbol?

ICU Medical trades on the NASDAQ under the ticker symbol "ICUI."

How do I buy shares of ICU Medical?

Shares of ICUI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is ICU Medical's stock price today?

One share of ICUI stock can currently be purchased for approximately $183.19.

How big of a company is ICU Medical?

ICU Medical has a market capitalization of $3.84 billion and generates $1.27 billion in revenue each year. The medical instruments supplier earns $101.04 million in net income (profit) each year or $7.36 on an earnings per share basis. ICU Medical employs 8,000 workers across the globe.

What is ICU Medical's official website?

The official website for ICU Medical is www.icumed.com.

How can I contact ICU Medical?

ICU Medical's mailing address is 951 CALLE AMANECER, SAN CLEMENTE CA, 92763. The medical instruments supplier can be reached via phone at 949-366-2183 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.